Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Still, a 2022 trial of tirzepatide reported hair loss or alopecia in about 5% to 6% of participants across doses, showing similar signals across studies
PubMed 9849822 Teichman SL, Neale A, Lawrence B, et al
Hepatotoxicity after 3-hydroxyacetanilide administration to buthionine sulfoximine pretreated mice
These prerequisites are: You have a body mass index (BMI) of 30 or more, indicating obesity You have a BMI of 27 or higher, categorised as overweight, coupled with at least one weight-related health condition such as high blood pressure or type 2 diabetes Is Wegovy available via the NHS
A missed dose creates its own questions but those questions are for your clinician, not the app
